These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 32592507)

  • 21. Triple therapy with hydroxychloroquine, azithromycin, and ciclesonide for COVID-19 pneumonia.
    Mori N; Katayama M; Nukaga S
    J Microbiol Immunol Infect; 2021 Feb; 54(1):109-112. PubMed ID: 33054978
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diabetes mellitus and COVID-19: A review and management guidance for South Africa.
    Coetzee A; Taljaard JJ; Hugo SS; Conradie M; Conradie-Smit M; Dave JA
    S Afr Med J; 2020 Jun; 110(8):761-766. PubMed ID: 32880304
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diabetes, obesity and COVID-19: A complex interplay.
    Vas P; Hopkins D; Feher M; Rubino F; B Whyte M
    Diabetes Obes Metab; 2020 Oct; 22(10):1892-1896. PubMed ID: 32627299
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Observational study on Effect of Lock Down due to COVID 19 on glycemic control in patients with Diabetes: Experience from Central India.
    Khare J; Jindal S
    Diabetes Metab Syndr; 2020; 14(6):1571-1574. PubMed ID: 32858474
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of hydroxychloroquine and azithromycin on SARS-CoV-2 clearance in COVID-19 patients, a meta-analysis.
    Million M; Roussel Y; Gautret P; Raoult D
    Int J Antimicrob Agents; 2021 Jan; 57(1):106240. PubMed ID: 33408019
    [No Abstract]   [Full Text] [Related]  

  • 26. Effect of COVID 19 pneumonia on hyperglycemia: Is it different from non COVID pneumonia?
    Knox DB; Hirshberg EL; Orme J; Peltan I; Lanspa MJ
    Diabetes Metab Syndr; 2022 Feb; 16(2):102407. PubMed ID: 35074624
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of hydroxychloroquine and chloroquine in patients with COVID-19: a meta-analysis of randomized clinical trials.
    Bignardi PR; Vengrus CS; Aquino BM; Cerci Neto A
    Pathog Glob Health; 2021 May; 115(3):139-150. PubMed ID: 33573530
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical Characteristics of Diabetic Patients with COVID-19.
    Li G; Deng Q; Feng J; Li F; Xiong N; He Q
    J Diabetes Res; 2020; 2020():1652403. PubMed ID: 32851093
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The possible mechanisms of action of 4-aminoquinolines (chloroquine/hydroxychloroquine) against Sars-Cov-2 infection (COVID-19): A role for iron homeostasis?
    Quiros Roldan E; Biasiotto G; Magro P; Zanella I
    Pharmacol Res; 2020 Aug; 158():104904. PubMed ID: 32430286
    [TBL] [Abstract][Full Text] [Related]  

  • 30. One year into the clash of pandemics of diabetes and COVID-19: Lessons learnt and future perspectives.
    Lui DTW; Lee CH; Tan KCB
    J Diabetes Investig; 2022 Jan; 13(1):19-21. PubMed ID: 34375500
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chloroquine and hydroxychloroquine in the treatment of COVID-19 with or without diabetes: A systematic search and a narrative review with a special reference to India and other developing countries.
    Singh AK; Singh A; Shaikh A; Singh R; Misra A
    Diabetes Metab Syndr; 2020; 14(3):241-246. PubMed ID: 32247211
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of hydroxychloroquine with or without azithromycin on the mortality of COVID-19 patients: authors' response.
    Fiolet T; Guihur A; Rebeaud ME; Mulot M; Peiffer-Smadja N; Mahamat-Saleh Y
    Clin Microbiol Infect; 2021 Jan; 27(1):138-140. PubMed ID: 33080383
    [No Abstract]   [Full Text] [Related]  

  • 33. Cardiovascular Risk in Diabetes Mellitus: Complication of the Disease or of Antihyperglycemic Medications.
    Alvarez CA; Lingvay I; Vuylsteke V; Koffarnus RL; McGuire DK
    Clin Pharmacol Ther; 2015 Aug; 98(2):145-61. PubMed ID: 25963811
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thresholds of Glycemia and the Outcomes of COVID-19 Complicated With Diabetes: A Retrospective Exploratory Study Using Continuous Glucose Monitoring.
    Shen Y; Fan X; Zhang L; Wang Y; Li C; Lu J; Zha B; Wu Y; Chen X; Zhou J; Jia W
    Diabetes Care; 2021 Apr; 44(4):976-982. PubMed ID: 33574126
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PROTECT Trial: A cluster-randomized study with hydroxychloroquine versus observational support for prevention or early-phase treatment of Coronavirus disease (COVID-19): A structured summary of a study protocol for a randomized controlled trial.
    Nanni O; Viale P; Vertogen B; Lilli C; Zingaretti C; Donati C; Masini C; Monti M; Serra P; Vespignani R; Grossi V; Biggeri A; Scarpi E; Galardi F; Bertoni L; Colamartini A; Falcini F; Altini M; Massa I; Gaggeri R; Martinelli G
    Trials; 2020 Jul; 21(1):689. PubMed ID: 32736597
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Can diabetes and its related hypoglycemic drug treatment be considered risk factors for health outcomes in COVID-19 patients? The results of a study in the population residing in Sicily Region (Southern Italy)].
    Cernigliaro A; Allotta AV; Scondotto S
    Epidemiol Prev; 2020; 44(5-6 Suppl 2):315-322. PubMed ID: 33412824
    [TBL] [Abstract][Full Text] [Related]  

  • 37. What makes (hydroxy)chloroquine ineffective against COVID-19: insights from cell biology.
    Altulea D; Maassen S; Baranov MV; van den Bogaart G
    J Mol Cell Biol; 2021 Jul; 13(3):175-184. PubMed ID: 33693723
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preinfection glycaemic control and disease severity among patients with type 2 diabetes and COVID-19: A retrospective, cohort study.
    Hayek S; Ben-Shlomo Y; Balicer R; Byrne K; Katz M; Kepten E; Raz I; Roitman E; Zychma M; Barda N
    Diabetes Obes Metab; 2021 Aug; 23(8):1995-2000. PubMed ID: 33822446
    [No Abstract]   [Full Text] [Related]  

  • 39. Possible mechanistic insights into iron homeostasis role of the action of 4-aminoquinolines (chloroquine/hydroxychloroquine) on COVID-19 (SARS-CoV-2) infection.
    Batiha GE; Shaheen HM; Al-Kuraishy HM; Teibo JO; Akinfe OA; Al-Garbee AI; Teibo TKA; Kabrah SM
    Eur Rev Med Pharmacol Sci; 2021 Dec; 25(23):7565-7584. PubMed ID: 34919258
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of postprandial glucose control on diabetes-related complications: How is the evidence evolving?
    Madsbad S
    J Diabetes Complications; 2016 Mar; 30(2):374-85. PubMed ID: 26541075
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.